Skip to content
ISCC

Welcome to the International Society of CIK Cells

The members of the International Society of CIK Cells (ISCC) want to improve treatment options for patients. To this end, they are researching and developing cancer treatment using cytokine-induced killer cells.

CIK cells play an important role in research und in clinics. They are already licensed as therapeutic option in various countries. More than 5,000 patients treated with CIK cells in clinical trials with only mild adverse events. The ISCC is founded in 2024 in order to foster networking of people interested in working with CIK cells. The ISCC will have the following functions: Coordination of the preparation of interdisciplinary guidelines, basic research, translational research, clinical research and unification of documents.

Dear patients,
dear colleagues,

welcome to our homepage.

The members of the International Society of CIK Cells (ISCC) want to improve the treatment options of patients. The ISCC is founded in 2024 in order to foster networking of people interested in working with CIK cells. You are welcome to become part of our society. Further information can be found on the following pages. If you have any questions or comments, please do not hesitate to contact us.

Best regards
Prof. Dr. med. Ingo Schmidt-Wolf
Director of the Department of Integrated Oncology

.$image->url.